SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)
To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.
| Condition(s) | Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups. |
| Who can participate | Inclusion Criteria: Both the patient and their family caregiver must meet the criteria to be considered for this research. 1. Patient 1. A person who has an advanced-stage solid cancer diagnosis (ICD-10 code C00-C70); A person who is receiving or planning to receive cancer treatment 2. A person who meets one of the following conditions 1. Has been evaluated as having ECOG performance status 2 2. Has been evaluated as having ECOG performance status 1 and is over 70 years of age 3. A person who wishes to stay at home 4. A person whose family caregiver resides at home 5. A person who wishes to participate in the research 2. Family Caregiver 1. A family\* member of the patient \* Family: refers to the patient's spouse (including a common-law partner), descendants and their spouses up to the se |
| Ages | 19 Years |
| Sex | All |
| Lead sponsor | Seoul National University Hospital |
| Locations | Goyang-si, Gyeonggi-do, South Korea; Seongnam-si, Gyeonggi-do, South Korea; Seongnam-si, Gyeonggi-do, South Korea; Seoul, South Korea; Seoul, South Korea; Seoul, South Korea |
| Start date | 2022-07-25 |
| NCT ID | NCT05636384 |
| Official listing | https://clinicaltrials.gov/study/NCT05636384 |